Anti-Streptococcus pneumoniae type 16 antibody (ab79526)

Overview

  • Product name
    Anti-Streptococcus pneumoniae type 16 antibody
  • Description
    Rabbit polyclonal to Streptococcus pneumoniae type 16
  • Specificity
    no crossreactivity wtih other serotypes observed
  • Tested applications
    Suitable for: Agglutinationmore details
  • Species reactivity
  • Immunogen

    Tissue/ cell preparation of Streptococcus pneumoniae type 16 (heat inactivated).

  • Positive control
    • Antigenic suspension
  • General notes
    Reagents should be allowed to stand at 15°C - 25°C for at least 30 minutes prior to use

Properties

  • Form
    Liquid
  • Storage instructions
    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage buffer
    Preservative: 0.08% Sodium Azide
    Constituents: Whole serum
  • Purity
    Whole antiserum
  • Clonality
    Polyclonal
  • Isotype
    IgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab79526 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Agglutination
  • Application notes
    Agg: See attached protocol.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • Relevance
      Bronchial pneumonia is most prevalant in infants, young children and aged adults. It is caused by various bacteria, including Streptococcus pneumoniae. Streptococcus pneumoniae are Gram positive, lancet shaped cocci (elongated cocci with a slightly pointed outer curvature). Usually they are seen as pairs of cocci (diplococci), but they may also occur singly and in short chains. S. pneumoniae is a transient member of the normal flora, colonizing the nasopharynx of 40% of healthy adults and children with no adverse effects. There are more than 90 serotypes: serotypes 6, 14, 18, 19, and 23 are the most prevalent accounting for 60-80% of infections depending on the area of the world. Pneumococcal infection accounts for more deaths than any other vaccine preventable bacterial disease.

    References

    ab79526 has not yet been referenced specifically in any publications.

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab79526.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

    Sign up